Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Becton, Dickinson and Co's
Operating Income
for the
three
months ended in Jun. 2022 was $592 Mil. Becton, Dickinson and Co's Interest Expense for the
three
months ended in Jun. 2022 was $-99 Mil.
Becton, Dickinson and Co's interest coverage for the quarter that ended in Jun. 2022 was 5.98.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Becton, Dickinson and Co's Interest Coverage or its related term are showing as below:
BDX'
s Interest Coverage Range Over the Past 10 Years
Min: 3.17 Med: 4.8 Max: 11.9
Current: 7.61
BDX's Interest Coverage is ranked worse than 80.9% of 424
companies
in the Medical Devices & Instruments industry
Industry Median: 38.10
vs BDX: 7.61
Becton, Dickinson and Co Interest Coverage Historical Data
The historical data trend for Becton, Dickinson and Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Becton, Dickinson and Co Annual Data
Trend
Sep12
Sep13
Sep14
Sep15
Sep16
Sep17
Sep18
Sep19
Sep20
Sep21
Interest Coverage
3.52
3.17
3.50
3.41
6.36
Becton, Dickinson and Co Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Interest Coverage
4.49
8.93
8.67
6.74
5.98
Competitive Comparison
For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton, Dickinson and Co Interest Coverage Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Becton, Dickinson and Co's Interest Coverage falls into.
Becton, Dickinson and Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton, Dickinson and Co (NYSE:BDX) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Becton, Dickinson and Co Interest Coverage Related Terms
Thank you for viewing the detailed overview of Becton, Dickinson and Co's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.67(0.26%) Volume: 1,126,874 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BDX has been successfully added to your 
